Clinical Trials Logo

Prostate Cancer Stage III clinical trials

View clinical trials related to Prostate Cancer Stage III.

Filter by:
  • None
  • Page 1

NCT ID: NCT03514927 Withdrawn - Clinical trials for Prostate Cancer Stage II

High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

This phase II trial studies how well high-intensity focused ultrasound works in treating participants with intermediate and high-risk prostate cancer. High-intensity focused ultrasound uses high frequency sound waves to deliver a strong beam which may target and destroy a specific part of the prostate, while minimizing damage to surrounding structures and tissue.

NCT ID: NCT03432780 Active, not recruiting - Clinical trials for Prostate Cancer Stage IV

Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer

QRT-SOGUG
Start date: December 18, 2008
Phase: Phase 2
Study type: Interventional

A prospective, multicenter, parallel-group, open-label, randomized, phase II Clinical Study of Radiation Therapy, Hormone Therapy and Docetaxel Versus Radiation Therapy and Hormone Therapy in Patients with High-Risk Localized Prostate Cancer (Stage III and IV) whose primary objective is determine the percentage of patients free of biochemical recurrence within 5 years of receiving a combination of radiation therapy with docetaxel associated with hormone therapy or the standard of care of radiation therapy and hormone therapy in patients with stage III and IV localized prostate cancer with a poor prognosis.